FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $265,000 | -1.5% | 4,535 | 0.0% | 0.05% | -41.1% |
Q3 2021 | $269,000 | -81.5% | 4,535 | -72.9% | 0.09% | -81.0% |
Q2 2021 | $1,452,000 | +441.8% | 16,730 | +415.1% | 0.47% | +382.7% |
Q1 2021 | $268,000 | -5.6% | 3,248 | +3.9% | 0.10% | -11.7% |
Q4 2020 | $284,000 | – | 3,126 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |